• 1
    Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:20952128.
  • 2
    Murray CJL, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:21972223.
  • 3
    Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8:355369.
  • 4
    Feigin V, Carter K, Hackett M et al. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002–2003. Lancet Neurol 2006; 5:130139.
  • 5
    Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke. Geneva, World Health Organization, 2004.
  • 6
    Tobias M, Cheung J, Carter K, Anderson C, Feigin VL. Stroke surveillance: population-based estimates and projections for New Zealand. Aust NZ J Public Health 2007; 31:520525.
  • 7
    Feigin V, Group obotARCSAS. Trends in stroke incidence in Auckland, New Zealand (1981–2003). Three decades of Auckland regional Community Stroke (ARCOS) studies: what have we learned and what is next for stroke care and stroke research? 2009:89.
  • 8
    Blakely T, Tobias M, Robson B, Ajwani S, Bonne M, Woodward A. Widening ethnic mortality disparities in New Zealand 1981–99. Soc Sci Med 2005; 61:22332251.
  • 9
    Dyall L, Feigin V, Brown P, Roberts M. Stroke: a picture of health disparities in New Zealand. Soc Policy J NZ 2008; 33:178191.
  • 10
    Fustinoni O, Biller J. Ethnicity and stroke: beware of the fallacies.[see comment]. Stroke 2000; 31:10131015.
  • 11
    Carter K, Anderson C, Hacket M et al. Trends in ethnic disparities in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke 2006; 37:5662.
  • 12
    McNaughton H, Feigin V, Kerse N et al. Ethnicity and functional outcome after stroke. Stroke 2011; 42:960964.
  • 13
    Brown P, Guy M, Broad J. Individual socio-economic status, community socio-economic status and stroke in New Zealand: a case control study. Soc Sci Med 2005; 61:11741188.
  • 14
    O'Donnell MJ, Xavier D, Liu L et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376:112123.
  • 15
    Bonita R, Beaglehole R. Stroke prevention in poor countries: time for action. Stroke 2007; 38:28712872.
  • 16
    Feigin VL, Rodgers A. Ethnic disparities in risk factors for stroke: what are the implications? Stroke 2004; 35:15681569.
  • 17
    Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007; 6:182187.
  • 18
    Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:3541.
  • 19
    Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337:15211526.
  • 20
    Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36:891901.
  • 21
    Ihle-Hansen H, Thommessen B, Wyller TB, Engedal K, Fure B. Risk factors for and incidence of subtypes of ischemic stroke. Funct Neurol 2012; 27:3540.
  • 22
    Sundborn G, Metcalf P, Schaaf D, Dyall L, Gentles D, Jackson R. Differences in health-related socioeconomic characteristics among Pacific populations living in Auckland, New Zealand. NZ Med J 2006; 119: No 1228.
  • 23
    Metcalf PA, Scagg RRK, Schaaf D, Dyall L, Black PN, Jackson RT. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factor in the diabetes, heart and health survey. NZ Med J 2008; 121:4556.
  • 24
    Health Mo. A Portrait of Health. Key Results of the 2006/07 New Zealand Health Survey. 2008.
  • 25
    Bray JE, Mosley I, Bailey M, Barger B, Bladin C. Stroke public awareness campaigns have increased ambulance dispatches for stroke in Melbourne, Australia. Stroke 2011; 42:21542157.
  • 26
    Pierce C, Fahs PS, Dura A et al. Raising stroke awareness among rural dwellers with a Facts for Action to Stroke Treatment-based educational program. Appl Nurs Res 2011; 24:8287.
  • 27
    Kim YS, Park S-S, Bae H-J et al. Stroke awareness decreases prehospital delay after acute ischemic stroke in Korea. BMC Neurol 2011; 11:2.
  • 28
    Alkadry MG, Bhandari R, Wilson CS, Blessett B. Racial disparities in stroke awareness: African Americans and Caucasians. J Health Hum Serv Adm 2011; 33:462490.
  • 29
    Payne GH, Fang J, Fogle CC et al. Stroke awareness: surveillance, educational campaigns, and public health practice. J Public Health Manag Pract 2010; 16:345358.
  • 30
    Hwang L-L, Lin H-C, Tseng M-C. Changes in stroke awareness among undergraduate students after an educational intervention. Acta Neurol Taiwan 2010; 19:9099.
  • 31
    Sacchetti ML, Di Mascio MT, Pelone G, Gallo V, Prencipe M. Targeting stroke awareness public campaigns. Stroke 2008; 39:e50.
  • 32
    Ryan T. Stroke awareness among British ethnic minorities. Br J Community Nurs 2010; 15:381384.
  • 33
    Wells S, Broad J, Jackson R. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers. NZ Med J 2006; 119(1232):U1935.
  • 34
    Mehta S, Wells S, Grey C et al. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16. Eur J Prev Cardiol 2012; October 2:111. DOI: 10.1177/2047487312462150.
  • 35
    WHO. Adherence to longterm therapies. Evidence for action. 2013.
  • 36
    Demaria AN. Adherence, compliance, concordance, or the lack thereof. J Am Coll Cardiol 2012; 59:11201121.
  • 37
    Mehta S, Wells S, Riddell T et al. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15). J Prim Health Care 2011; 3:93101.